Navigation Links
Throat Culture

ProductsThroat Culture
Company ARUP Laboratories
Item Throat Culture
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. 3.5V MacroViewOtoscope/Throat Illuminator
2. 2.5V PocketScope Otoscope/Throat Illuminator
3. Culture Incubator
4. Pathfinder Chlamydia Culture Confirmation Test
5. E. Coli Enrichment Culture Strip
6. E. Coli Enrichment Culture Cassette
7. Abscess Culture
8. Acanthamoeba Culture
9. Actinomyces Culture
10. Adenovirus Culture
11. AFB Culture (Includes AFB Stain 0060151)
...reg; PLUS Biomaterial is the first hernia repair m...ing potential operative contamination of the mater...antimicrobial preservative agents, silver carbonat...t bacterial colonization on the patch for up to 10...
...the Bard Kugel Patch, which is constructed of a do...o layers create a positioning pocket, which is use...the other side is a barrier of ePTFE. The patch al...," which causes the patch to spring open and maint...
...eshaped Mesh is constructed of Bard polypropylene ...40 years. Developed with the world renowned Lichte...sh takes the guesswork out of sizing and shaping t...inal hernia repair procedure.,Its three-dimension...
...mesh is a three-dimensional, anatomically formed p...he Bard 3DMax mesh has been designed based on care...l canal. The result is a truly unique prosthesis f...oduct is constructed of Bard mesh, knitted polypro...
Medicine Products:
(Date:5/16/2008)...,s Bed & Back; Merger Sets Up Healthy Back as...ain, LORTON, Va., May 16 /PRNewswire/ -- Healthy ...and workplace back wellness created an,ergonomic r...its rival,JoAnne,s Bed & Back. Healthy Back,s 18 ...s of $40million. JoAnne,s 16 mid-Atlantic stores,c...
(Date:5/16/2008)...wire-USNewswire/ -- This release is,being sent in ...on with the,National Cancer Institute, part of the...he American Society of Clinical,Oncology meeting i...ractice,in about 25 percent of patients with colon...he way colorectal cancers will be staged., * This...
(Date:5/16/2008)...s gain benefit from calcitriol, an oral form , ... activated vitamin D may cut the risk of death for...ease by about one quarter, a new study suggests. ...tients, those being treated with calcitriol, an or...risk of death lowered by 26 percent when compared ...
(Date:5/16/2008)...aise $38 Million for Life-threatening,Disease, BE...kers in nearly,every state will raise funds for cy...participating in GREAT STRIDES, the largest nation...announced today., May is National Cystic Fibrosis...ening genetic disease that causes fatal lung infec...
Breaking Medicine News(10 mins):Health News:The Back Wars Come to a Close 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2
... assistants, typically graduate students hired to ... college campuses. Indiana University shyness expe...eople hired to help new students with their conver...become staples, as well. New students, said Cardu...
...trial body recognizing the downward trend of acces...wo things needed to reverse the situation- more mo... According to the Federation of Indian Chambers ...dia needs to spend around $203 billion (Rs 912,37...
...traditional diet of fish, tofu, vegetables and ric...r, but a change of eating habits is weighing down...ry estimates that every second male and every fift...and experts have identified a change in lifestyle ...
...udy has found that what boys lose in the process o...parts of the penis. The long-term-health impact ...y, while the consequences of circumcision on sexua... male have received even less attention. But now,...
Other Medicine News:Health News:Binge Drinking on College Campuses is a Matter of Fear, Not Freedom 2Health News:Binge Drinking on College Campuses is a Matter of Fear, Not Freedom 3Health News:FICCI Proposes Models To Solve Indias Healthcare Crisis 2Health News:Japanese are Weighed Down by Deviating from Their Traditional Diet 2
(Date:5/16/2008)...wswire-FirstCall/ -- Pulmo BioTech Inc. (OTC,Bulle...ethodology and,purpose of its Phase I Human Trials...or the diagnosis of Pulmonary Embolism and Pulmona... the Pulmo BioTech subsidiary,PulmoScience Inc., ...e Use,of PulmoBind for Molecular Imaging of the Pu...
(Date:5/16/2008).../- BioVex Inc, a biotechnology,compan...nd infectious,disease, announced today that the ab...se II clinical trial of OncoVEX GM-CSF in advanced...can Society of Clinical Oncology,(ASCO) website lo...bstract,which describes the data as of the submiss...
(Date:5/16/2008).../- Veridex, LLC announced today that,... of America Holdings,(LabCorp), has commercially l...ancer. The new assay uses the biological specifici...ing the methylation of the gene,GST-Pi. Methylatio...n,cancer. Veridex is developing the methylation ma...
(Date:5/15/2008)...May 15 /- Eisai Corporation of North,...cal data abstracts about,compounds in the company,...ical oncology research have been accepted for pres...n Society of Clinical Oncology (ASCO),taking plac... variety of abstracts on Eisai marketed products a...
Breaking Medicine Technology:Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Sea otter study reveals striking variability in diets and feeding strategies 1893 1Sea otter study reveals striking variability in diets and feeding strategies 1893 2Sea otter study reveals striking variability in diets and feeding strategies 1893 3Three Rivers Pharmaceuticals 28R 29 LLC Acquires Hepatitis C Drug Infergen 28R 29 from Valeant Pharmaceuticals 9529 1Three Rivers Pharmaceuticals 28R 29 LLC Acquires Hepatitis C Drug Infergen 28R 29 from Valeant Pharmaceuticals 9529 2Huron Capital Caps Strong Year With Five Acquisitions In 4Q07 9527 1Huron Capital Caps Strong Year With Five Acquisitions In 4Q07 9527 2Huron Capital Caps Strong Year With Five Acquisitions In 4Q07 9527 3Sickle Cell Disease Pain Can Occur Daily and Is Much More Severe Than Previously Thought 9525 1Sickle Cell Disease Pain Can Occur Daily and Is Much More Severe Than Previously Thought 9525 2
...., June 26, 2007 /PRNewswire-FirstCall/ -- Microme...the development of,novel, proprietary antibody-bas...e diseases, announced that a study published recen...Sciences (1) supports,the findings of several othe... target for Micromet,s product candidates adecatum...
...(BUSINESS WIRE)--Jun 27, 2007 - CytRx Corporation,... in the,development and commercialization of human... the six-month, open-label extension,of its comple...LS,volunteers. While the clinical trial was not pl...ee times daily appeared to be safe,and well-tolera...
Other Medicine Technology:Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 2Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 3Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 4CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 2CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 3CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 4CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 5